Eastgate Biotech Corp Valuation
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Eastgate Biotech Corp from reviewing the firm fundamentals such as Price To Sales of 1.49 X, shares outstanding of 2.06 B, and EBITDA of (3.55 M) as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Eastgate Biotech's price fluctuation is very steady at this time. Calculation of the real value of Eastgate Biotech Corp is based on 3 months time horizon. Increasing Eastgate Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eastgate Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eastgate Stock. However, Eastgate Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0045 | Real 0.004085 | Hype 0.005625 | Naive 0.004294 |
The intrinsic value of Eastgate Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Eastgate Biotech's stock price.
Estimating the potential upside or downside of Eastgate Biotech Corp helps investors to forecast how Eastgate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eastgate Biotech more accurately as focusing exclusively on Eastgate Biotech's fundamentals will not take into account other important factors: Eastgate Biotech Total Value Analysis
Eastgate Biotech Corp is currently forecasted to have valuation of 18.92 M with market capitalization of 205.75 K, debt of 1.67 M, and cash on hands of 4.91 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Eastgate Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.92 M | 205.75 K | 1.67 M | 4.91 K |
Eastgate Biotech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Eastgate signifies not a very effective usage of assets in December.Eastgate Biotech Profitability Analysis
Net Loss for the year was (2.98 M) with profit before overhead, payroll, taxes, and interest of 0.About Eastgate Biotech Valuation
An absolute valuation paradigm, as applied to Eastgate Stock, attempts to find the value of Eastgate Biotech Corp based on its fundamental and basic technical indicators. By analyzing Eastgate Biotech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Eastgate Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eastgate Biotech. We calculate exposure to Eastgate Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eastgate Biotech's related companies.Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |